- 155.5k views
Bronchial Asthma: Management
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.
About the Speaker
Dr. Prashant Saxena
Associate Director & Head, Pulmonology, Critical Care & Sleep Medicine, Fortis Hospital
Dr. Prashant holds clinical expertise in the managing critically ill patients and various respiratory conditions. As a Chairperson of Cardiac Resuscitation Committee, he has introduced the concept of Rapid Response Team for patients in order to decrease the numbers of unexpected events in the hospital.
Upcoming Case Discussions
Gynaecologist’s Guide to Ovarian Cancer
Join us for a special webinar on World Ovarian Cancer Day, titled "Gynaecologist’s Guide to Ovarian Cancer." This expert-led session will delve into the latest advancements in early diagnosis, risk stratification, and evidence-based management of ovarian cancer. Tailored for gynecologists and healthcare professionals, the session will also explore real-world case discussions and multidisciplinary treatment approaches. Let’s come together to raise awareness and empower clinicians in the fight against this silent but deadly disease
Massive Transfusion Protocol
Massive Transfusion Protocol (MTP) is a standardized medical procedure activated in cases of severe hemorrhage, typically involving the rapid administration of large volumes of blood products. The goal is to restore circulating volume, maintain hemostasis, and prevent the lethal triad of hypothermia, acidosis, and coagulopathy. MTP usually involves a balanced ratio of packed red blood cells, plasma, and platelets, often in a 1:1:1 ratio. Early activation and coordination among trauma teams, laboratory services, and blood banks are essential for its success.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Prashant Saxena's Talks on Assimilate
- 27th-September-2023, TIME : 06:00PM - 07:00PM
- 0
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.
- 27th-September-2023, TIME : 06:00PM - 07:00PM
- 0
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.
- 27th-September-2023, TIME : 06:00PM - 07:00PM
- 0
The management of bronchial asthma focuses on controlling and alleviating symptoms to improve a patient's quality of life. This involves two key components: long-term control and quick-relief (rescue) medications. Long-term control medications, often in the form of inhaled corticosteroids or leukotriene modifiers, are used to reduce airway inflammation and prevent asthma symptoms. Quick-relief medications, such as short-acting beta-agonists, provide immediate relief during asthma attacks. Patients also benefit from creating an asthma action plan, which includes monitoring symptoms, recognizing triggers, and knowing when to seek medical help. A collaborative approach between healthcare providers and patients is essential in tailoring the treatment plan to individual needs and ensuring optimal asthma management.